Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ka F To

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
BMC Cancer|July 4, 2019
Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancerTung H Ng, Kathy W Y Sham, Chuan M Xie, et al.
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
Cancer Letters|November 5, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesisFeng Wu, Liangliang Xu, Yalin Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaAnthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
The New England Journal of Medicine|December 27, 2002
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritisFrancis K L Chan, Lawrence C T Hung, Bing Y Suen, et al.
Theranostics|March 21, 2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic featuresXiangchun Li, Weiqi Xu, Wei Kang, et al.
Gastroenterology|December 17, 2008
Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancerJun Yu, Yuen Y Cheng, Qian Tao, et al.
BMC Cancer|May 13, 2015
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseWinnie Yeo, Stephen L Chan, Frankie K F Mo, et al.
Gastroenterology|March 4, 2003
Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopyJoseph J Y Sung, Francis K L Chan, Wai K Leung, et al.
Cancer Research|April 23, 2011
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesisAlfred S L Cheng, Suki S Lau, Yangchao Chen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 4, 2019
Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancerTung H Ng, Kathy W Y Sham, Chuan M Xie, et al.
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
Cancer Letters|November 5, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesisFeng Wu, Liangliang Xu, Yalin Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaAnthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
The New England Journal of Medicine|December 27, 2002
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritisFrancis K L Chan, Lawrence C T Hung, Bing Y Suen, et al.
Theranostics|March 21, 2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic featuresXiangchun Li, Weiqi Xu, Wei Kang, et al.
Gastroenterology|December 17, 2008
Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancerJun Yu, Yuen Y Cheng, Qian Tao, et al.
BMC Cancer|May 13, 2015
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseWinnie Yeo, Stephen L Chan, Frankie K F Mo, et al.
Gastroenterology|March 4, 2003
Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopyJoseph J Y Sung, Francis K L Chan, Wai K Leung, et al.
Cancer Research|April 23, 2011
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesisAlfred S L Cheng, Suki S Lau, Yangchao Chen, et al.
Pageof 5